A trans-fatty acid-rich diet promotes liver tumorigenesis in HCV core gene transgenic mice.
Animals
Carcinogenesis
/ pathology
Carcinoma, Hepatocellular
/ genetics
Cell Proliferation
Dietary Fats
/ administration & dosage
Disease Models, Animal
Fibrosis
Hepacivirus
/ genetics
Hepatitis C
/ genetics
Humans
Liver
/ pathology
Liver Neoplasms
/ genetics
MAP Kinase Signaling System
Male
Mice
Mice, Transgenic
Risk Factors
Trans Fatty Acids
/ administration & dosage
Up-Regulation
Viral Core Proteins
/ genetics
Wnt Signaling Pathway
Journal
Carcinogenesis
ISSN: 1460-2180
Titre abrégé: Carcinogenesis
Pays: England
ID NLM: 8008055
Informations de publication
Date de publication:
22 04 2020
22 04 2020
Historique:
received:
23
12
2018
revised:
08
06
2019
accepted:
11
07
2019
pubmed:
14
7
2019
medline:
1
9
2020
entrez:
14
7
2019
Statut:
ppublish
Résumé
Excess consumption of trans-fatty acid (TFA), an unsaturated fatty acid containing trans double bonds, is a major risk factor for cardiovascular disease and metabolic syndrome. However, little is known about the link between TFA and hepatocellular carcinoma (HCC) despite it being a frequent form of cancer in humans. In this study, the impact of excessive dietary TFA on hepatic tumorigenesis was assessed using hepatitis C virus (HCV) core gene transgenic mice that spontaneously developed HCC. Male transgenic mice were treated for 5 months with either a control diet or an isocaloric TFA-rich diet that replaced the majority of soybean oil with shortening. The prevalence of liver tumors was significantly higher in TFA-rich diet-fed transgenic mice compared with control diet-fed transgenic mice. The TFA-rich diet significantly increased the expression of pro-inflammatory cytokines, as well as oxidative and endoplasmic reticulum stress, and activated nuclear factor-kappa B (NF-κB) and nuclear factor erythroid 2-related factor 2 (NRF2), leading to high p62/sequestosome 1 (SQSTM1) expression. Furthermore, the TFA diet activated extracellular signal-regulated kinase (ERK) and stimulated the Wnt/β-catenin signaling pathway, synergistically upregulating cyclin D1 and c-Myc, driving cell proliferation. Excess TFA intake also promoted fibrogenesis and ductular reaction, presumably contributing to accelerated liver tumorigenesis. In conclusion, these results demonstrate that a TFA-rich diet promotes hepatic tumorigenesis, mainly due to persistent activation of NF-κB and NRF2-p62/SQSTM1 signaling, ERK and Wnt/β-catenin pathways and fibrogenesis. Therefore, HCV-infected patients should avoid a TFA-rich diet to prevent liver tumor development.
Identifiants
pubmed: 31300810
pii: 5531913
doi: 10.1093/carcin/bgz132
pmc: PMC8456504
doi:
Substances chimiques
Dietary Fats
0
Trans Fatty Acids
0
Viral Core Proteins
0
nucleocapsid protein, Hepatitis C virus
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
159-170Informations de copyright
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Références
Hepatology. 2002 Jun;35(6):1341-50
pubmed: 12029619
N Engl J Med. 2006 Apr 13;354(15):1601-13
pubmed: 16611951
J Biol Chem. 2015 Jan 30;290(5):3092-105
pubmed: 25477509
J Clin Invest. 2008 Feb;118(2):683-94
pubmed: 18188449
Nat Med. 1998 Sep;4(9):1065-7
pubmed: 9734402
Biochem Biophys Res Commun. 2018 Nov 17;506(1):12-19
pubmed: 30333090
J Biol Chem. 1998 Mar 6;273(10):5678-84
pubmed: 9488698
JAMA Intern Med. 2016 Aug 1;176(8):1134-45
pubmed: 27379574
Pharmacol Ther. 2017 Nov;179:142-157
pubmed: 28546081
Nature. 2012 Feb 01;482(7384):179-85
pubmed: 22297845
Hepatology. 2019 Jan;69(1):420-430
pubmed: 30070383
J Mol Med (Berl). 2004 Jul;82(7):434-48
pubmed: 15175863
Hepatology. 2012 Jul;56(1):118-29
pubmed: 22290395
Arch Toxicol. 2019 Jun;93(6):1713-1725
pubmed: 31004178
Mol Nutr Food Res. 2009 Jul;53(7):897-903
pubmed: 19685549
Nat Rev Endocrinol. 2009 Jun;5(6):335-44
pubmed: 19399016
Prog Lipid Res. 1983;22(3):221-33
pubmed: 6356151
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3170-3182
pubmed: 28844958
Biochim Biophys Acta. 2007 Aug;1773(8):1263-84
pubmed: 17126425
PLoS One. 2010 Mar 02;5(3):e9434
pubmed: 20209147
Oncogene. 1999 Nov 22;18(49):6853-66
pubmed: 10602461
Int J Cancer. 2008 Jan 1;122(1):124-31
pubmed: 17764115
World J Gastroenterol. 2018 Apr 7;24(13):1440-1450
pubmed: 29632425
Cancer Biol Ther. 2006 Jan;5(1):111-7
pubmed: 16397407
J Nutr Biochem. 2017 Jan;39:77-85
pubmed: 27816763
Cancer Cell. 2016 Jun 13;29(6):935-948
pubmed: 27211490
Cancer Res. 2008 Jun 1;68(11):4287-95
pubmed: 18519688
Nature. 2011 Jul 06;475(7354):106-9
pubmed: 21734707
Prog Lipid Res. 1993;32(1):111-22
pubmed: 8415796
Liver Cancer. 2013 Aug;2(3-4):365-6
pubmed: 24400223
J Hepatol. 2011 Apr;54(4):795-809
pubmed: 21145844
Biochim Biophys Acta. 2015 Jul;1852(7):1242-52
pubmed: 25736301
Hepatol Res. 2017 Apr;47(5):405-418
pubmed: 27288988
Cancers (Basel). 2011 May 20;3(2):2462-77
pubmed: 24212819
J Biol Chem. 2000 Jan 28;275(4):2247-50
pubmed: 10644669
Cell Res. 2002 Mar;12(1):9-18
pubmed: 11942415
Mol Cell Biol. 1999 Jan;19(1):1-11
pubmed: 9858526
Oncogene. 2017 Oct 26;36(43):6020-6029
pubmed: 28671671
Genes Dev. 2000 Aug 1;14(15):1837-51
pubmed: 10921899
Biochim Biophys Acta. 2014 Nov;1841(11):1596-607
pubmed: 25178843
Mol Cell Biol. 1994 Feb;14(2):1039-44
pubmed: 8289784
Gastroenterol Res Pract. 2010;2010:362847
pubmed: 21274430
J Gen Virol. 1997 Jul;78 ( Pt 7):1527-31
pubmed: 9225025
J Hepatol. 2014 Feb;60(2):331-8
pubmed: 24096051
N Engl J Med. 2003 Apr 24;348(17):1625-38
pubmed: 12711737
Mol Cell Endocrinol. 2013 Aug 15;375(1-2):157-66
pubmed: 23732116
Nature. 2004 Sep 23;431(7007):461-6
pubmed: 15329734